Загрузка...
Improvement of Antibody Responses by HIV Envelope DNA and Protein Co-Immunization
BACKGROUND: Developing HIV Envelope (Env) vaccine components that elicit durable and protective antibody responses is an urgent priority, given the results from the RV144 trial. Optimization of both the immunogens and vaccination strategies will be needed to generate potent, durable antibodies. Due...
Сохранить в:
| Главные авторы: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3926420/ https://ncbi.nlm.nih.gov/pubmed/24280279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2013.11.022 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|